Thursday, September 18, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

ALK MEETING AIMS TO HELP MORE PEOPLE WITH ALLERGIES GET BETTER CARE

Robyn Maginnis by Robyn Maginnis
20 September 2022
in Latest
0
ALK MEETING AIMS TO HELP MORE PEOPLE WITH ALLERGIES GET BETTER CARE

Over 60 delegates from Danish pharmaceutical company ALK (Allergology Laboratory Kopenhagen) arrived in Dublin for a three-day meeting entitled “Helping more people with allergy get better care”. This is a briefing meeting for the Irish, UK and Benelux teams for the rest of 2022.

 ALK is a global, research-driven pharmaceutical company focusing on allergy prevention, diagnosis and treatment. A world leader in allergy, ALK specialises in allergy immunotherapy; which not only reduces allergic symptoms but also treats the underlying cause of specific allergies. ALK has approximately 2,000 employees with subsidiaries, production facilities and distributors worldwide.                                

This is the first time the teams from these areas have met since 2019 due to Covid travel restrictions. The meeting was also attended by ALK Executive Vice Presidents Søren Niegel and Søren Jelert and Sean Connor, Regional General Manager Northern Europe.  

Danish Ambassador to Ireland, Lars Theusen, who recently moved from the UK, opened the meeting and welcomed the delegates to Dublin.  ALK has had representation in Ireland since 2015, however, in recent years the sales team has expanded. This growth has come as the company successfully secured marketing authorisation for 3 new allergy immunotherapy treatments in Ireland, including one for the treatment of adult allergic asthma. Asthma prevalence in Ireland is among the highest in the world.  It is the most common chronic disease affecting children and the most common chronic respiratory disease in adults. There is one death per week from asthma in Ireland.

ALK has also committed to increasing allergy education through the support of an educational grant to University College Cork. The emphasis will be on education through the support of postgraduate allergy training courses. ALK was also one of a small number of companies to sponsor the European Academy of Allergy and Clinical Immunology Summer School on Food Allergy. This event was hosted in University College Cork recently with approximately 150 delegates from across Europe in attendance.

Sean Connor, UK General Manager of ALK says, “ALK is committed to improving the health of people suffering with allergy across the globe and ensuring that health inequalities are minimised. In Ireland, we see large numbers of people who do not have access to life-changing allergy medications when compared to the rest of Europe. ALK intends to change this injustice and have over the last couple of years registered three new products for which we are actively seeking reimbursement so that all patients can access these medicines.”

For more information about ALK visit https://www.alk.net. 

Previous Post

Today marks the 15th annual Awareness Week for AMD – the leading cause of sight loss for those aged over 50

Next Post

The Alzheimer Society of Ireland Welcomes Funding for Dementia Supports in Budget 2023

Next Post
The Alzheimer Society of Ireland Welcomes Funding for Dementia Supports in Budget 2023

The Alzheimer Society of Ireland Welcomes Funding for Dementia Supports in Budget 2023

Inizio appoints Ryan Quigley as its new Chief Executive Officer to lead its next phase of growth

Inizio appoints Ryan Quigley as its new Chief Executive Officer to lead its next phase of growth

17 September 2025
Topic Team Training – Dehydration

Topic Team Training – Dehydration

16 September 2025
CPD: Emergency Contraception

CPD: Emergency Contraception

16 September 2025

RECOMMENDED NEWS

MINISTER FOR HEALTH TO ASSIST PATIENTS ACCESS THEIR MEDICINAL CANNABIS PRODUCTS DURING COVID-19

5 years ago
Pain in Children – Team training

Pain in Children – Team training

3 years ago
Customer Service Training in Pharmacy

Customer Service Training in Pharmacy

1 year ago
Migraine Care in Ireland

Migraine Care in Ireland

1 year ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN